$2.54
0.0652.63%
At close: Aug 13, 5:00 PM EST
$2.12
-0.42-16.37%
After Hours: 7:11 PM EST
Innate Pharma SA Earnings Estimates
IPHANASDAQ
Innate Pharma Earnings Estimates, EPS & Revenue | NASDAQ:IPHA
Innate Pharma (IPHA) is scheduled to report H1 earnings on September 16, 2026. Analysts estimate EPS of $-0.16 and quarterly revenue of $9.1M.
In the most recent quarter (FY), Innate Pharma reported EPS of $-0.64, beating estimates of $-0.65 by 0.02%. Revenue came in at $10.48M, exceeding the estimate of $7.23M by 0.45%.
Earnings Date
Sep 16
EPS Estimate
$-0.160
Quarterly Revenue Estimate
$9.1M
Annual Revenue
$2.79M
as of Dec 31
Innate Pharma Earnings History
Analyze the earnings history of Innate Pharma using advanced sorting and filters.
Innate Pharma (IPHA) Earnings Per Share
The chart below shows Innate Pharma's reported EPS compared to analyst estimates over recent quarters.
Innate Pharma (IPHA) Revenue
The chart below shows Innate Pharma's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Innate Pharma (NASDAQ:IPHA) reporting earnings?
Innate Pharma (IPHA) is scheduled to report earnings on September 16, 2026. The last reported earnings were for reported on March 26, 2026 for FY.
What were the latest earnings per share (EPS) for Innate Pharma (NASDAQ:IPHA)?
The Actual EPS was $-0.64, which beat the estimate of $-0.65.
What were Innate Pharma’s (NASDAQ:IPHA) revenues?
The Actual Revenue was $10.48M, which beat the estimate of $7.23M.
